| http://dbpedia.org/ontology/abstract
|
Relcovaptan (SR-49059) is a non-peptide va … Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype. It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic, although it is not yet approved for clinical use.h it is not yet approved for clinical use.
|
| http://dbpedia.org/ontology/casNumber
|
150375-75-0
|
| http://dbpedia.org/ontology/chEMBL
|
419667
|
| http://dbpedia.org/ontology/fdaUniiCode
|
C1GL8G6G0O
|
| http://dbpedia.org/ontology/pubchem
|
60943
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Relcovaptan.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
20699915
|
| http://dbpedia.org/ontology/wikiPageLength
|
3127
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1033037991
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Vasopressin_receptor_antagonist +
, http://dbpedia.org/resource/Dysmenorrhoea +
, http://dbpedia.org/resource/Arginine_vasopressin_receptor_1A +
, http://dbpedia.org/resource/Raynaud%27s_disease +
, http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
, http://dbpedia.org/resource/Tocolytic +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
28
|
| http://dbpedia.org/property/casNumber
|
150375
|
| http://dbpedia.org/property/chembl
|
419667
|
| http://dbpedia.org/property/chemspiderid
|
54910
|
| http://dbpedia.org/property/cl
|
2
|
| http://dbpedia.org/property/h
|
27
|
| http://dbpedia.org/property/iupacName
|
1
|
| http://dbpedia.org/property/iupharLigand
|
2200
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
7
|
| http://dbpedia.org/property/pubchem
|
60943
|
| http://dbpedia.org/property/s
|
1
|
| http://dbpedia.org/property/smiles
|
COC1=COC
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
CEBYCSRFKCEUSW-NAYZPBBASA-N
|
| http://dbpedia.org/property/synonyms
|
(-1-[-5-chloro-3--1-sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide)
|
| http://dbpedia.org/property/unii
|
C1GL8G6G0O
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
455170527
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/width
|
220
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Systemic-hormonal-drug-stub +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Oxytocin_and_vasopressin_receptor_modulators +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antagonist +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Relcovaptan?oldid=1033037991&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Relcovaptan.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Relcovaptan +
|
| owl:sameAs |
http://dbpedia.org/resource/Relcovaptan +
, http://www.wikidata.org/entity/Q7310905 +
, http://sh.dbpedia.org/resource/Relkovaptan +
, http://vi.dbpedia.org/resource/Relcovaptan +
, http://rdf.freebase.com/ns/m.0523pnj +
, http://yago-knowledge.org/resource/Relcovaptan +
, https://global.dbpedia.org/id/4tpUJ +
, http://sr.dbpedia.org/resource/Relkovaptan +
, http://fa.dbpedia.org/resource/%D8%B1%D9%84%DA%A9%D9%88%D9%88%D8%A7%D9%BE%D8%AA%D8%A7%D9%86 +
|
| rdf:type |
http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/WikicatHormonalAgents +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Agent109190918 +
|
| rdfs:comment |
Relcovaptan (SR-49059) is a non-peptide va … Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype. It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic, although it is not yet approved for clinical use.h it is not yet approved for clinical use.
|
| rdfs:label |
Relcovaptan
|
